• No se han encontrado resultados

TítuloImplicaciones de la hormona de crecimiento, hormonas gastrointestinales, irisina y "microARNs" en la obesidad

N/A
N/A
Protected

Academic year: 2020

Share "TítuloImplicaciones de la hormona de crecimiento, hormonas gastrointestinales, irisina y "microARNs" en la obesidad"

Copied!
277
0
0

Texto completo

Loading

Figure

Figura 1.2. Vías de la regulación central de la ingesta a largo plazo (Palou, Bonet et al
Figura 1.3. Esquema de la acción central y periférica de la leptina (Palou, Bonet et al
Figura 1.4. Señales en la regulación de la ingesta a corto plazo (Palou, Bonet et al. 2004)
Tabla 1.5. Síntomas y signos asociados a cada déficit hormonal hipofisario (Schneider, Aimaretti et al
+7

Referencias

Documento similar

Abstract: Background Background: Insulin-like growth factor 1 (IGF-1) seems to be involved in the neural circuits associated with social cognition and brain

pastoris has the ability to grow at different acceptable specific growth rates (µ) depending on the temperature of the medium (from 15ºC to 30ºC), lowering the

(2015) Human Epidermal Growth Factor Receptor 2 (HER2)–specific chimeric antigen receptor–modified T cells for the Immunotherapy of HER2- positive sarcoma.. Journal of

Effects of basic fibroblast growth factor on early revascularization and epithelial regeneration in rabbit tracheal orthotopic transplantation. Comparative anatomy, physíology,

The skin phenotype of TR KO mice with defective response to proliferative stimuli, retarded hair growth and impaired wound healing would be compatible with the existence of a defect

Growth regulation of human colon cancer cells by epidermal growth factor and 1,25-dihydroxyvitamin D 3 is mediated by mutual modulation of receptor expression. The down-regulation

(A) Relative GH receptor (GHR) protein levels in control rats (C); rats receiving acute central administration of insulin (CI); pair-fed rats (PF); pair-fed rats treated with

Methods Cross-sectional, multicentre, observational study conducted to determine the effectiveness—measured by control of serum insulin-like growth factor 1 (IGF-1) —of